In vitro antimicrobial efficacy of a fixed-dose combination of RHZE against M. tuberculosis
ABSTRACT The use of drugs in fixed-dose combination (FDC) is now recommended by the World Health Organization (WHO) due to the emergence of multidrug-resistant strains of Mycobacterium tuberculosis. FDC uses different drugs against tuberculosis (TB) in a single tablet for phase-intensive therapeutic...
Saved in:
Main Authors: | Vanessa Albertina Agertt (Author), Pauline Cordenonsi Bonez (Author), Caren Rigon Mizdal (Author), Grazielle Guidolin Rossi (Author), Vanessa da Costa Flores (Author), Marli Matiko Anraku de Campos (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of mycobacteria isolated at University Hospital of Santa Maria, Rio Grande do Sul, Brazil
by: Vanessa Albertina Agertt, et al.
Published: (2013) -
Molecular characterization of Enterobacteriaceae resistant to carbapenem antimicrobials
by: Jaciane B. Marques, et al.
Published: (2015) -
The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis
by: Blomberg Bjørn, et al.
Published: (2001) -
Dispersible fixed-dose combinations of antituberculous drugs... Finally available!!
by: Antoni Noguera-Julian, et al.
Published: (2024) -
Fixed dosed combinations in the treatment of hypertension
by: Gabriel Hancu, et al.
Published: (2020)